ATE203171T1 - Gerät zum behandeln von tumoren mittels selektiver proteinverringerung - Google Patents

Gerät zum behandeln von tumoren mittels selektiver proteinverringerung

Info

Publication number
ATE203171T1
ATE203171T1 AT94924858T AT94924858T ATE203171T1 AT E203171 T1 ATE203171 T1 AT E203171T1 AT 94924858 T AT94924858 T AT 94924858T AT 94924858 T AT94924858 T AT 94924858T AT E203171 T1 ATE203171 T1 AT E203171T1
Authority
AT
Austria
Prior art keywords
blood
cells
concentration
molecular weight
tumor cells
Prior art date
Application number
AT94924858T
Other languages
English (en)
Inventor
Slobodan Tepic
Original Assignee
Slobodan Tepic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slobodan Tepic filed Critical Slobodan Tepic
Application granted granted Critical
Publication of ATE203171T1 publication Critical patent/ATE203171T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3431—Substitution fluid path upstream of the filter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3475—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate with filtrate treatment agent in the same enclosure as the membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
AT94924858T 1993-08-10 1994-08-09 Gerät zum behandeln von tumoren mittels selektiver proteinverringerung ATE203171T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10498493A 1993-08-10 1993-08-10
PCT/EP1994/002640 WO1995004560A1 (en) 1993-08-10 1994-08-09 Treatment of tumors by selective protein depletion

Publications (1)

Publication Number Publication Date
ATE203171T1 true ATE203171T1 (de) 2001-08-15

Family

ID=22303469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94924858T ATE203171T1 (de) 1993-08-10 1994-08-09 Gerät zum behandeln von tumoren mittels selektiver proteinverringerung

Country Status (7)

Country Link
EP (1) EP0671958B1 (de)
JP (1) JP3573349B2 (de)
AT (1) ATE203171T1 (de)
AU (1) AU7498994A (de)
CA (1) CA2146754A1 (de)
DE (1) DE69427745T2 (de)
WO (1) WO1995004560A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2069695A (en) * 1995-03-13 1996-10-02 Ao Forschungsinstitut Davos An extracorporeal blood treatment apparatus and method for removal of free circulating infectious agents
DE10154317B4 (de) 2001-10-26 2005-06-09 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben
FR2852515B1 (fr) * 2003-03-17 2005-11-18 Dispositif et procede de traitement de sang avec extraction selective de solutes
US7291269B2 (en) 2003-03-17 2007-11-06 Gambro Lundia Ab Apparatus and process for extracorporeal treatment of blood with selective extraction of solutes
DE102007039939B4 (de) * 2007-08-23 2013-03-14 Albutec Gmbh Vorrichtung zur Einsparung von Diafiltrat
EP2113257A1 (de) * 2008-04-30 2009-11-04 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelektrolyt mit positiver Überschussladung zur Verwendung als Medikament und Diagnose von Krebs
JP2013532031A (ja) * 2010-06-22 2013-08-15 ジェイジェイケイ メディカル リミテッド 新規な媒体、装置および方法
SE1200356A1 (sv) 2011-10-30 2013-05-01 Kurt Nilsson Polymerbaserad produkt och användning
CN103263704B (zh) * 2013-05-09 2015-10-28 浙江大学 配备储浆袋的血浆置换吸附滤过净化系统
DE102013105304A1 (de) * 2013-05-23 2014-11-27 Osram Opto Semiconductors Gmbh Verfahren zur Herstellung eines pulverförmigen Precursormaterials, pulverförmiges Precursormaterial und seine Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1096208B (it) * 1978-05-12 1985-08-26 Snam Progetti Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa
US4955857A (en) * 1988-07-18 1990-09-11 Shettigar Udipi R Multi-enzyme bioreactor therapy for cancer

Also Published As

Publication number Publication date
DE69427745T2 (de) 2002-05-23
CA2146754A1 (en) 1995-02-16
JP3573349B2 (ja) 2004-10-06
EP0671958A1 (de) 1995-09-20
AU7498994A (en) 1995-02-28
EP0671958B1 (de) 2001-07-18
WO1995004560A1 (en) 1995-02-16
JPH08506262A (ja) 1996-07-09
DE69427745D1 (de) 2001-08-23

Similar Documents

Publication Publication Date Title
Sasaki et al. Stable complex of fibrinogen and fibrin
DE3382723T2 (de) Adsorbens und Verfahren zu dessen Herstellung.
ATE51754T1 (de) Verfahren zur selektiven adsorption von heparin.
Forell et al. The influence of bile and pure bile salts on pancreatic secretion in man
ATE203171T1 (de) Gerät zum behandeln von tumoren mittels selektiver proteinverringerung
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
AU6933900A (en) Method, reagent and test cartridge for determining clotting time
Man et al. Uremic neurotoxin in the middle molecular weight range
Zhang et al. Gold binding sites in red blood cells
Reznek et al. Plasma-myoinositol concentrations in uraemic neuropathy
DE69428995T2 (de) Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin
Drinkard et al. Calcium binding by organic matrix of developing bovine enamel
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
RU2195322C2 (ru) Способ лечения и профилактики печеночной недостаточности путем детоксикации крови
JP2675019B2 (ja) 悪性腫瘍治療剤の製造方法およびそれに用いられる装置
Gordan A direct action of parathyroid hormone on dead bone in vitro
Lohmann et al. The importance of SH-containing substances for red blood cells in acute myeloic leukemia
RU1252991C (ru) Способ лечени отравлений фосфорорганическими соединени ми
Vincent The Effect of Carbon Monoxide Exposure on Erythropoietic Activity in the Sprague-Dawley Rat
RU2139099C1 (ru) Способ лечения ангионевротического отека
SU1074493A1 (ru) Способ гемосорбции
Chen et al. (Na+-K+) atpase activity in erythrocyte membranes of spontaneously, one kidney-one wrapped, and deoxycorticosterone acetatenacl hypertensive rats
SU1053833A1 (ru) Способ детоксикации организма
Pourrat et al. On-line plasma reprocessing by convective electrophoresis
Smith Time-Action Relationships of the Specific Inhibitor of Caudal Regeneration in Clymenella tor quata.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties